Please assess the completion status of the following clinical trial:

Trial Title: nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female at least 18 years of age at time of screening.~* Willingness and ability to comply with study procedures and visit schedules and able to follow oral and written instructions.~* A standing knee radiograph showing a K-L grade of 2 to 4~* Body mass index ≤ 40 kg/m2~* A qualifying WOMAC LK 3.1 pain subscale total score~* Signed an ethics committee-reviewed and approved informed consent form.~Exclusion Criteria:~* Presence of clinically observed active infection in the index knee~* Presence of symptomatic OA in the non-study knee at screening~* Diagnosed with rheumatoid arthritis, Reiter's syndrome, psoriatic arthritis, gout, ankylosing spondylitis, or arthritis secondary to other inflammatory diseases; HIV, viral hepatitis; chondrocalcinosis, Paget's disease, or villonodular synovitis~* Diagnosed with leukemia, known presence of metastatic malignant cells, or ongoing or planned chemotherapeutic treatment~* Presence of venous or lymphatic stasis in the index leg~* A history of local anesthetic allergy~* Previously documented failed treatment with nSTRIDE APS or Synvisc One

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- nSTRIDE APS (Type: ACTIVE_COMPARATOR): The nSTRIDE APS Kit is designed to be used for the safe and rapid preparation of APS from a small sample of blood at the patient's point of care. The APS is to be injected intra-articularly for the treatment of knee osteoarthritis and associated symptoms.
- Synvisc-One (Type: ACTIVE_COMPARATOR): Synvisc-One is only intended for intra-articular use by a physician to treat pain associated with osteoarthritis of the knee

Based on this trial design, predict the completion outcome and termination type (if applicable).